Cumberland Pharmaceuticals (CPIX) Long-Term Debt Repayments: 2010-2025
Historic Long-Term Debt Repayments for Cumberland Pharmaceuticals (CPIX) over the last 9 years, with Mar 2025 value amounting to $10.0 million.
- Cumberland Pharmaceuticals' Long-Term Debt Repayments rose 30.33% to $10.0 million in Q1 2025 from the same period last year, while for Mar 2025 it was $38.3 million, marking a year-over-year increase of 11.23%. This contributed to the annual value of $36.0 million for FY2024, which is 3.17% up from last year.
- Cumberland Pharmaceuticals' Long-Term Debt Repayments amounted to $10.0 million in Q1 2025, which was up 58.90% from $6.3 million recorded in Q4 2024.
- Cumberland Pharmaceuticals' 5-year Long-Term Debt Repayments high stood at $20.0 million for Q2 2022, and its period low was $6.3 million during Q4 2024.
- Moreover, its 3-year median value for Long-Term Debt Repayments was $8.1 million (2023), whereas its average is $9.0 million.
- In the last 5 years, Cumberland Pharmaceuticals' Long-Term Debt Repayments skyrocketed by 76.47% in 2021 and then plummeted by 45.82% in 2023.
- Cumberland Pharmaceuticals' Long-Term Debt Repayments (Quarterly) stood at $14.0 million in 2021, then tumbled by 45.00% to $7.7 million in 2022, then climbed by 1.80% to $7.8 million in 2023, then declined by 19.44% to $6.3 million in 2024, then soared by 30.33% to $10.0 million in 2025.
- Its last three reported values are $10.0 million in Q1 2025, $6.3 million for Q4 2024, and $11.0 million during Q3 2024.